dc.creator | Blach-Olszewska Z. | |
dc.creator | Zaczynska E. | |
dc.creator | Gustaw-Rothenberg K. | |
dc.creator | Avila-Rodrigues M. | |
dc.creator | Barreto G.E. | |
dc.creator | Leszek J. | |
dc.creator | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:13:12Z | |
dc.date.accessioned | 2022-11-08T20:24:39Z | |
dc.date.available | 2020-09-02T22:13:12Z | |
dc.date.available | 2022-11-08T20:24:39Z | |
dc.date.created | 2020-09-02T22:13:12Z | |
dc.date.issued | 2015 | |
dc.identifier | 21, 25, 3582-3588 | |
dc.identifier | 13816128 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3765 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145351 | |
dc.language | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Alzheimer disease | |
dc.subject | Human peripheral blood leukocytes | |
dc.subject | Innate immunity | |
dc.subject | Therapy | |
dc.subject | cyclooxygenase 2 inhibitor | |
dc.subject | donepezil | |
dc.subject | galantamine | |
dc.subject | Ginkgo biloba extract | |
dc.subject | immunosuppressive agent | |
dc.subject | natural product | |
dc.subject | nonsteroid antiinflammatory agent | |
dc.subject | steroid | |
dc.subject | tumor necrosis factor | |
dc.subject | cholinesterase inhibitor | |
dc.subject | immunologic factor | |
dc.subject | interferon | |
dc.subject | nonsteroid antiinflammatory agent | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | Alzheimer disease | |
dc.subject | Article | |
dc.subject | autoimmunity | |
dc.subject | extract | |
dc.subject | gene expression | |
dc.subject | human | |
dc.subject | immunopathogenesis | |
dc.subject | immunosuppressive treatment | |
dc.subject | infection resistance | |
dc.subject | inflammation | |
dc.subject | innate immunity | |
dc.subject | leukocyte | |
dc.subject | mild cognitive impairment | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | steroid therapy | |
dc.subject | virus infection | |
dc.subject | aging | |
dc.subject | Alzheimer disease | |
dc.subject | animal | |
dc.subject | drug development | |
dc.subject | drug effects | |
dc.subject | immunology | |
dc.subject | innate immunity | |
dc.subject | metabolism | |
dc.subject | microglia | |
dc.subject | oxidative stress | |
dc.subject | Aging | |
dc.subject | Alzheimer Disease | |
dc.subject | Animals | |
dc.subject | Anti-Inflammatory Agents, Non-Steroidal | |
dc.subject | Cholinesterase Inhibitors | |
dc.subject | Drug Discovery | |
dc.subject | Humans | |
dc.subject | Immunity, Innate | |
dc.subject | Immunologic Factors | |
dc.subject | Interferons | |
dc.subject | Leukocytes | |
dc.subject | Microglia | |
dc.subject | Oxidative Stress | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.title | The innate immunity in alzheimer disease-relevance to pathogenesis and therapy | |
dc.type | Article | |